AU1807592A - New combination preparation for treatment of parkinson's disease - Google Patents

New combination preparation for treatment of parkinson's disease

Info

Publication number
AU1807592A
AU1807592A AU18075/92A AU1807592A AU1807592A AU 1807592 A AU1807592 A AU 1807592A AU 18075/92 A AU18075/92 A AU 18075/92A AU 1807592 A AU1807592 A AU 1807592A AU 1807592 A AU1807592 A AU 1807592A
Authority
AU
Australia
Prior art keywords
parkinson
disease
treatment
new combination
combination preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18075/92A
Inventor
Peter-Andreas Loschmann
Helmut Wachtel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU1807592A publication Critical patent/AU1807592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU18075/92A 1991-06-05 1992-06-05 New combination preparation for treatment of parkinson's disease Abandoned AU1807592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4118740A DE4118740A1 (en) 1991-06-05 1991-06-05 NEW COMBINATION DEVICES FOR TREATING MORBUS PARKINSON
DE4118740 1991-06-05

Publications (1)

Publication Number Publication Date
AU1807592A true AU1807592A (en) 1992-12-10

Family

ID=6433409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18075/92A Abandoned AU1807592A (en) 1991-06-05 1992-06-05 New combination preparation for treatment of parkinson's disease

Country Status (9)

Country Link
EP (1) EP0517347A1 (en)
JP (1) JPH05170668A (en)
AU (1) AU1807592A (en)
CA (1) CA2070494A1 (en)
DE (1) DE4118740A1 (en)
HU (1) HUT64473A (en)
IE (1) IE921824A1 (en)
IL (1) IL102095A0 (en)
ZA (1) ZA924128B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2700117B1 (en) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application of anti-convulsants in the treatment of Parkinson's disease and parkinsonian syndromes.
GB9305692D0 (en) * 1993-03-19 1993-05-05 Wellcome Found Therapeutic triazine compounds and use
RU2176145C2 (en) * 1995-05-26 2001-11-27 Пфайзер Инк. Synergetic treatment of parkinsonism
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
RU2020100230A (en) 2017-06-12 2021-07-13 Глитек Ллс. TREATMENT OF DEPRESSION WITH NMDA ANTAGONISTS AND D2 / 5-HT2A ANTAGONISTS OR SELECTIVE 5-HT2A ANTAGONISTS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940410A1 (en) * 1989-12-04 1991-06-06 Schering Ag NEW USE OF NMDA RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
EP0517347A1 (en) 1992-12-09
JPH05170668A (en) 1993-07-09
DE4118740A1 (en) 1992-12-10
CA2070494A1 (en) 1992-12-06
HU9201874D0 (en) 1992-08-28
ZA924128B (en) 1993-03-25
HUT64473A (en) 1994-01-28
IL102095A0 (en) 1993-01-14
IE921824A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
AU8392291A (en) Tachykinin agonists for treatment of alzheimer's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU4048295A (en) Peptide medicaments for the treatment of disease
AU7715491A (en) A therapeutic preparation containing myrrh for treating skin disorders
AU8910891A (en) Treatment of lung diseases
AU1790988A (en) Phosphoethanolamine for treatment of alzheimer's disease
IL95946A0 (en) Preparation of tetrabromo-4,4'-alkylidenediphenols
AU4759390A (en) Method of medical treatment of alzheimer's disease
AU7556994A (en) Methods for the diagnosis of alzheimer's disease
AU1674492A (en) Alzheimer's disease treatment with tacrine metabolites
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU2806692A (en) Medicament for the treatment of anxiety
AU1807592A (en) New combination preparation for treatment of parkinson's disease
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
EP0389110A3 (en) Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
AU8185491A (en) Treatment of disease
AU3027692A (en) Compositions for the treatment of mammalian diseases
EP0666745A4 (en) Diagnosis and therapy for parkinson's disease.
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
AU7737991A (en) Medical uses of m-csf
EP0486584A4 (en) Dopaminergic neurotrophic factor for treatment of parkinson's disease
AU5702890A (en) Therapeutic agents of metabolic bone disease
AU1023992A (en) Process for the preparation of 3'-fluoropyrimidine nucleosides